<DOC>
	<DOCNO>NCT00483106</DOCNO>
	<brief_summary>Attention deficit hyperactivity disorder ( ADHD ) common behavioral problem childhood . It estimate 80 % disorder could relate genetic factor . The common treatment ADHD psychostimulants . In study , researcher investigate effect genetic variant increase risk behaviour pertinent ADHD modulate response behaviour methylphenidate . Response methylphenidate evaluate double blind placebo control one week study .</brief_summary>
	<brief_title>Clinical Pharmacogenetic Study Attention Deficit With Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>ADHD Psychosis Tourette syndrome Intelligence quotient ( IQ ) &lt; 70 Pervasive developmental disorder ( PDD )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Genetics</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>